Cargando…
A Comparison of Parenteral Phenobarbital vs. Parenteral Phenytoin as Second-Line Management for Pediatric Convulsive Status Epilepticus in a Resource-Limited Setting
Introduction: Pediatric convulsive status epilepticus (CSE) which is refractory to first-line benzodiazepines is a significant clinical challenge, especially within resource-limited countries. Parenteral phenobarbital is widely used in Africa as second-line agent for pediatric CSE, however evidence...
Autores principales: | Burman, Richard J., Ackermann, Sally, Shapson-Coe, Alexander, Ndondo, Alvin, Buys, Heloise, Wilmshurst, Jo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530138/ https://www.ncbi.nlm.nih.gov/pubmed/31156538 http://dx.doi.org/10.3389/fneur.2019.00506 |
Ejemplares similares
-
Is it a Tie at This Point in the Game? Efficacy of Levetiracetam and Phenytoin for the Second-Line Treatment of Convulsive Status Epilepticus
por: Vossler, David G.
Publicado: (2019) -
Phenytoin induced chorea in a pediatric patient: An interaction between phenytoin, phenobarbital and clobazam
por: Barvaliya, Manish, et al.
Publicado: (2011) -
A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study
por: Dalziel, Stuart R., et al.
Publicado: (2017) -
Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial
por: Lyttle, Mark D, et al.
Publicado: (2019) -
Effect of S‐1 on blood levels of phenobarbital and phenytoin: A case report
por: Shiraiwa, Ken, et al.
Publicado: (2021)